Change in number of shares and votes in Oncopeptides AB (publ)
During April, the number of shares and votes in Oncopeptides AB (publ) (”Oncopeptides” or the ”Company”) has increased by 977 906 shares and votes due to the new issue of shares that was made in connection with the exercise of the over-allotment option, subsequent to the listing of the Company’s shares on Nasdaq Stockholm. As of April 28, 2017, the number of shares and votes in Oncopeptides amounts to 39,806,021. About OncopeptidesOncopeptides is a research and development stage pharmaceutical company developing drugs for the treatment of cancer. Since the founding of the company